| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0033 | 1 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |